High quality raw material for IVD manufacturing industry

Recombinant antigen p30 (SAG1) for Toxoplasma gondii

RekomBiotech
Toxoplasma gondii

Major surface antigen p30 (SAG1) induces significant levels of p30 antibodies in all patients with toxoplasmosis. Purified p30 has been tested for its potential to induce protective immunity in mice and for serodiagnosis of Toxoplasma infection.

View more information about Toxoplasmosis.

REFERENCES
RAG0011 (E. coli) WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
RAG0019 (P. pastoris) WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
GENE
SAG1
DESCRIPTION
Major surface antigen
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Toxoplasmosis
IVD
Serodiagnosis of human and animal toxoplasmosis
EVALUATION
SAG1 (p30) from Toxoplasma gondii requires maintain its native conformation to detect IgM antibodies.
PROMOTIONAL MATERIAL
Catalogue
RELATED PRODUCTS
p35 (GRA8), ChimToxo1

Also avaliable for detection of Toxoplasmosis in animals

FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)

(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS